The new OOD was compared to OTD at identical total daily doses ( TDD : 40-120mg / day ) employing intensive , five times daily current pain ( 0-100mm visual analog scale , VAS ) and twice daily 12h recalled pain assessments as well as safety parameters such as nausea and sedation ( VAS ) over 5 days for each treatment ( after a 5day run-in phase ) .